- Home
- SABS vs EQS Comparison
SABS vs EQS Comparison
Compare SABS & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- EQS
- Stock Information
- Founded
- SABS 2014
- EQS 1991
- Country
- SABS United States
- EQS United States
- Employees
- SABS N/A
- EQS N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- SABS Health Care
- EQS Finance
- Exchange
- SABS Nasdaq
- EQS Nasdaq
- Market Cap
- SABS 31.2M
- EQS 25.8M
- IPO Year
- SABS N/A
- EQS N/A
- Fundamental
- Price
- SABS $4.09
- EQS $1.78
- Analyst Decision
- SABS Strong Buy
- EQS
- Analyst Count
- SABS 3
- EQS 0
- Target Price
- SABS $9.00
- EQS N/A
- AVG Volume (30 Days)
- SABS 203.1K
- EQS 6.0K
- Earning Date
- SABS 11-13-2025
- EQS 01-01-0001
- Dividend Yield
- SABS N/A
- EQS N/A
- EPS Growth
- SABS N/A
- EQS N/A
- EPS
- SABS N/A
- EQS N/A
- Revenue
- SABS $114,698.00
- EQS $1,377,000.00
- Revenue This Year
- SABS N/A
- EQS N/A
- Revenue Next Year
- SABS N/A
- EQS N/A
- P/E Ratio
- SABS N/A
- EQS N/A
- Revenue Growth
- SABS N/A
- EQS 21.11
- 52 Week Low
- SABS $1.00
- EQS $0.74
- 52 Week High
- SABS $6.60
- EQS $2.49
- Technical
- Relative Strength Index (RSI)
- SABS 71.11
- EQS 47.32
- Support Level
- SABS $3.68
- EQS $1.74
- Resistance Level
- SABS $4.15
- EQS $1.97
- Average True Range (ATR)
- SABS 0.31
- EQS 0.11
- MACD
- SABS 0.04
- EQS 0.00
- Stochastic Oscillator
- SABS 93.18
- EQS 43.33
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.